Pyran Expands to Bring High-Performance, Bio-Based Diol to the Market
Pyran, Inc. announced that it is expanding sales of 1,5-pentanediol (PDO) to select, pre-approved customers as it has achieved critical milestones necessary to begin operating its world-scale commercial plant for the product in 2026. After securing an additional $1.5 million in new funding, Pyran has scaled its technology and produced ton quantities of its bio-based product.
The company announced it is now selling its product to early customers to allow them to qualify the bio-based product in their applications. Potential customers interested in obtaining a sample should contact the company.